1 min read
Add as a preferred source on Google

Eli Lilly Sued Over Rep’s Retaliation Claim Tied to Alleged Off-Label Mounjaro Promotion

Jennifer Mansion alleges Eli Lilly and Co. fired her after she objected to its alleged off-label promotion of Mounjaro for weight loss, an unapproved use at the time.

An unmarked injector rests beside a quiet courthouse corridor / TokenPost.ai
An unmarked injector rests beside a quiet courthouse corridor / TokenPost.ai

Jennifer Mansion, a sales representative for Eli Lilly and Co., alleges the company fired her in retaliation for objecting to its alleged off-label promotion of Mounjaro for weight loss, an unapproved use at the time.

Mansion's complaint says Lilly terminated her on Nov. 9, 2023, after she raised those objections. She filed the lawsuit on Nov. 9, 2026. The claim that the firing was retaliation is an allegation, not an established court finding.

Riza Dagoc

Riza Dagoc reports on regulation, investing and the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…